Back to Journals » OncoTargets and Therapy » Volume 13

Coronin3 Promotes Nasopharyngeal Carcinoma Migration and Invasion by Induction of Epithelial-to-Mesenchymal Transition [Retraction]

Authors Fan L, Wei Y, Ding X, Li B 

Received 21 July 2020

Accepted for publication 21 July 2020

Published 28 July 2020 Volume 2020:13 Pages 7355—7356

DOI https://doi.org/10.2147/OTT.S273162



Fan L, Wei Y, Ding X, Li B. Onco Targets Ther. 2019;12:9585–9598.


At the request of the authors, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article.


We were notified by the authors of potential issues relating to the reliability of the data in the published article. There was also some potential image duplication in Figure 5: 

● Figure 5A Migration Panel CNE-1-vector appears to be duplicated with Figure 5A Invasion CNE-1-vector.

● Figure 5A Migration Panel CNE-1-C3 appears to be duplicated with Figure 5A Invasion CNE-1-C3.
● Figure 5D CNE-2-ShCntrl Panel 24H appears to be duplicated with Figure 5D CNE-2-ShC3 Panel 24H.


The authors were unable to provide the required raw data for this study and the editor determined the findings of the study were no longer supported and agreed with the authors request for the article to be retracted. The authors wish to apologise for this error.


Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.